APA (7th ed.) Citation

Lee, Y. R., & Yeo, S. (2020). Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety. Clinical Drug Investigation, 40(10), 901. https://doi.org/10.1007/s40261-020-00955-x

Chicago Style (17th ed.) Citation

Lee, Young Ran, and Suyeon Yeo. "Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety." Clinical Drug Investigation 40, no. 10 (2020): 901. https://doi.org/10.1007/s40261-020-00955-x.

MLA (9th ed.) Citation

Lee, Young Ran, and Suyeon Yeo. "Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety." Clinical Drug Investigation, vol. 40, no. 10, 2020, p. 901, https://doi.org/10.1007/s40261-020-00955-x.